insights_auto
Why is ENSC up 15.07%?
Dive Deeperchevron_right
ENSC:NASDAQ
Ensysce Biosciences Inc
$0.53
arrow_upward
+15.07%(+0.069) 1D
$0.52
arrow_downward
-1.31% (-0.0069)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ENSC...
Open
$0.48
High
$0.55
Low
$0.48
Mkt. cap
10.21M
Avg. vol.
504.36K
Volume
2.67M
52-wk high
$2.75
52-wk low
$0.23
EPS
-$2.75
Beta
1.01
Shares outstanding
19.46M
No. of employees
9
Open
$0.48
High
$0.55
Low
$0.48
Mkt. cap
10.21M
Avg. vol.
504.36K
Volume
2.67M
52-wk high
$2.75
52-wk low
$0.23
EPS
-$2.75
Beta
1.01
Shares outstanding
19.46M
No. of employees
9
News stories
From web sources and news partners
TradingView
·
50 minutes ago
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
Yahoo Finance
·
1 hour ago
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Quiver Quantitative
·
1 hour ago
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
Seeking Alpha
·
40 minutes ago
Depreciation Subtleties: S&P Earnings Are Vastly Overstated (NYSEARCA:SPY)
About Ensysce Biosciences Inc
CEO-
Employees9
Founded2003
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Websiteensysce.com